Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a human oncoprotein which is overexpressed in many cancers, including hepatocellular carcinoma (HCC), lung, colon, prostate, ovarian, cervical, breast, head and neck cancers and leukemia [1]. This evidence concerns the gene CIP2A and head and neck cancer.